New York City-based pharmaceutical company Pfizer Inc is planning on investing $600 million in biotechnology and other emerging growth companies through Pfizer Ventures. About 25 percent of the funding will focus on neuroscience.
{iframe}https://www.pehub.com/2018/06/pfizer-commits-600-mln-vc-unit/#.WxhuC28rvP4.email{/iframe}